ResearcherSeoul National UniversityNo recent work listed

Hye In Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0839-4086; OpenAlex author ID A5100648771. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

Consolidatory ablative stereotactic body radiation therapy after induction chemotherapy for unresectable pancreatic cancer: A single center experience. Co-author DOI 10.3389/fonc.2022.974454 ↗
NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant Pancreatic Cancer Cells by Suppressing HO-1 and ABCG2 Expression. Co-author DOI 10.3390/ijms21134646 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hyun‐Cheol Kang · 1 shared paper, 2022 · strength 0.26
- Paper Consolidatory ablative stereotactic body radiation therapy after induction chemotherapy for unresectable pancreatic can… DOI 10.3389/fonc.2022.974454 ↗
Eui Kyu Chie · 1 shared paper, 2022 · strength 0.26
- Paper Consolidatory ablative stereotactic body radiation therapy after induction chemotherapy for unresectable pancreatic can… DOI 10.3389/fonc.2022.974454 ↗
Eui Joo Kim · 1 shared paper, 2020 · strength 0.13
- Paper NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant Pancreatic Cancer Cells by Suppressing HO-1 and ABCG2 Expression. DOI 10.3390/ijms21134646 ↗
Jae Hee Cho · 1 shared paper, 2020 · strength 0.13
- Paper NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant Pancreatic Cancer Cells by Suppressing HO-1 and ABCG2 Expression. DOI 10.3390/ijms21134646 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.